HK1123501A1 - Treatment of length dependent neuropathy - Google Patents

Treatment of length dependent neuropathy

Info

Publication number
HK1123501A1
HK1123501A1 HK09101396.9A HK09101396A HK1123501A1 HK 1123501 A1 HK1123501 A1 HK 1123501A1 HK 09101396 A HK09101396 A HK 09101396A HK 1123501 A1 HK1123501 A1 HK 1123501A1
Authority
HK
Hong Kong
Prior art keywords
painful
treatment
neuropathy
length dependent
patients
Prior art date
Application number
HK09101396.9A
Other languages
English (en)
Inventor
James N Campbell
Original Assignee
Arcion Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arcion Therapeutics Inc filed Critical Arcion Therapeutics Inc
Publication of HK1123501A1 publication Critical patent/HK1123501A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4168—1,3-Diazoles having a nitrogen attached in position 2, e.g. clonidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Oscillators With Electromechanical Resonators (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK09101396.9A 2005-11-08 2009-02-13 Treatment of length dependent neuropathy HK1123501A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73442305P 2005-11-08 2005-11-08
PCT/US2006/043499 WO2007056460A2 (en) 2005-11-08 2006-11-07 Treatment of length dependent neuropathy

Publications (1)

Publication Number Publication Date
HK1123501A1 true HK1123501A1 (en) 2009-06-19

Family

ID=37946498

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09101396.9A HK1123501A1 (en) 2005-11-08 2009-02-13 Treatment of length dependent neuropathy

Country Status (16)

Country Link
EP (2) EP2343068A3 (xx)
JP (2) JP5044566B2 (xx)
KR (1) KR101389184B1 (xx)
CN (2) CN101365445A (xx)
AT (1) ATE493128T1 (xx)
AU (2) AU2006311580B2 (xx)
CA (1) CA2628794C (xx)
CY (1) CY1112190T1 (xx)
DE (1) DE602006019311D1 (xx)
DK (1) DK1962836T3 (xx)
ES (1) ES2357033T3 (xx)
HK (1) HK1123501A1 (xx)
PL (1) PL1962836T3 (xx)
PT (1) PT1962836E (xx)
SI (1) SI1962836T1 (xx)
WO (1) WO2007056460A2 (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012012333A1 (en) * 2010-07-19 2012-01-26 Arcion Therapeutics, Inc. Topical treatment of neuropathic pain and methods of diagnosis
CN101947222A (zh) * 2010-08-18 2011-01-19 徐震 一种用于治疗高血压的软膏剂及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5447947A (en) 1990-02-26 1995-09-05 Arc 1 Compositions and methods of treatment of sympathetically maintained pain
EP0573581A4 (en) * 1991-02-26 1994-06-29 Arc 1 Inc Compositions and methods of treatment of sympathetically maintained pain
DK0901790T3 (da) * 1997-09-16 2001-08-06 Solvay Pharm Gmbh Anvendelse af moxonidin til behandling af neuropatisk smerte
US6147102A (en) 1999-10-26 2000-11-14 Curatek Pharmaceuticals Holding, Inc. Clonidine preparations
US7687080B2 (en) * 2002-11-25 2010-03-30 Taraxos Inc. Treatment of neuropathy
US20090325975A1 (en) * 2005-07-15 2009-12-31 Helmut H Buschmann Use of compounds binding to the sigma receptor for the treatment of diabetes-associated pain

Also Published As

Publication number Publication date
EP1962836B1 (en) 2010-12-29
CA2628794C (en) 2012-01-03
AU2006311580A1 (en) 2007-05-18
EP1962836A2 (en) 2008-09-03
ES2357033T3 (es) 2011-04-15
AU2010214659B2 (en) 2012-02-02
WO2007056460A2 (en) 2007-05-18
WO2007056460A3 (en) 2007-08-23
ATE493128T1 (de) 2011-01-15
PT1962836E (pt) 2011-03-01
AU2006311580B2 (en) 2010-06-24
CY1112190T1 (el) 2015-12-09
KR101389184B1 (ko) 2014-04-24
DE602006019311D1 (de) 2011-02-10
JP5044566B2 (ja) 2012-10-10
JP2009514970A (ja) 2009-04-09
CN105147674A (zh) 2015-12-16
CA2628794A1 (en) 2007-05-18
DK1962836T3 (da) 2011-02-28
PL1962836T3 (pl) 2011-06-30
SI1962836T1 (sl) 2011-04-29
CN101365445A (zh) 2009-02-11
EP2343068A2 (en) 2011-07-13
EP2343068A3 (en) 2012-06-13
KR20080091756A (ko) 2008-10-14
JP2012097121A (ja) 2012-05-24
AU2010214659A1 (en) 2010-09-16

Similar Documents

Publication Publication Date Title
BRPI0410169A (pt) dispositivo manual para aplicação de um material de barreira a uma mecha de cabelos; e método para aplicação de um material de barreira a uma mecha de cabelos a ser tratada
US6921529B2 (en) Treatment modality and method for fungal nail infection
JP4931128B2 (ja) Ｔｒｐｖ１アゴニストの投与のための方法および組成物
CA1306692C (en) Penetration enhancers for transdermal delivery of systemic agents
EA200301200A1 (ru) Проникающая через кожу композиция селективного ингибитора циклооксигеназы-2
JP2001354591A (ja) 爪甲真菌症処置の方法
US20040057919A1 (en) Antifungal composition and method for human nails
KR20070085773A (ko) 사마귀 치료를 위한 장치와 방법
TW200502017A (en) Active agent delivery device having composite members
CA2602018A1 (en) A transdermal topical composition and its uses
WO2007098591A2 (en) Topical nail formulation
HUE034680T2 (en) Transdermal pharmaceutical compositions containing SERM
RU2009139896A (ru) Композиции по уходу за кожей, содержащие салициловую кислоту
JP2014518239A (ja) 皮膚反応を低減するための新規な安定麻酔組成物
WO2002005834A3 (en) Novel uses for thyroid hormones or thyroid hormone-like agonist compounds for treating dermis conditions
HK1123501A1 (en) Treatment of length dependent neuropathy
GB2478159A (en) Composition for the treatment of fungal nail infection
WO2006113796A3 (en) Microbial cellulose materials for use in transdermal drug delivery system
CA2674379A1 (en) Method of treating hyperesthesia, paresthesia, dolor, and pruritus caused by insect stings or noxious weeds or plants using avermectin compound
BRPI0414112A (pt) uso de oxcarbazepina para o tratamento de dor neuropática diabética e a melhora do sono
AR045178A1 (es) Uso de un componente retinoide seleccionado entre el grupo formado por agentes retinoides activos, precursores de agentes retinoides activos y mezclas de los mismos, para preparar una composicion farmaceutica
JP2008505914A (ja) ギルソナイト由来医薬送達組成物および方法：美容および爪用途
JP6016085B2 (ja) 抗真菌外用組成物及び抗真菌外用組成物の適用方法
CN115836052A (zh) (1s)-1-苯基-2-吡啶-2-基乙胺的局部制剂
TH87784B (th) สูตรเฉพาะที่มี o-เดสเมทธิลเวนลาฟาซีน(odv)หรือเกลือของมัน

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20171107